SS
RPRX icon

SBI Securities’s Royalty Pharma RPRX Stock Holding History

SBI Securities’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Sell
37,489
-2,197
-6% -$114K 0.05% 189
2026
Q1 		$1.9M Sell
39,686
-2,066
-5% -$90.5K 0.05% 192
2025
Q4 		$1.61M Sell
41,752
-4,500
-10% -$172K 0.04% 210
2025
Q3 		$1.63M Sell
46,252
-3,687
-7% -$133K 0.04% 214
2025
Q2 		$1.8M Sell
49,939
-2,923
-6% -$96.8K 0.05% 195
2025
Q1 		$1.65M Sell
52,862
-680
-1% -$21.6K 0.05% 190
2024
Q4 		$1.37M Buy
+53,542
New +$1.42M 0.04% 208

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's RPRX Position: Q2 2026 in Review

SBI Securities reduced its Royalty Pharma (RPRX) stake by 5.5% in Q2 2026, selling an estimated $114K and leaving 37,489 shares worth $2.1M. The position accounts for 0.05% of the portfolio, ranked #189.

SBI Securities first reported a position in RPRX in Q4 2024 and has held it in 7 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • SBI Securities held 37,489 shares of Royalty Pharma worth $2.1M as of Q2 2026.
  • SBI Securities sold 2,197 Royalty Pharma shares in Q2 2026, an estimated $114K.
  • Royalty Pharma made up 0.05% of SBI Securities's portfolio in Q2 2026, its #189 holding.
  • SBI Securities first reported a position in Royalty Pharma in Q4 2024 and has held it in 7 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.